AVBP
Price
$18.78
Change
+$0.12 (+0.64%)
Updated
Aug 4 closing price
Capitalization
689.14M
8 days until earnings call
KYMR
Price
$43.66
Change
+$0.70 (+1.63%)
Updated
Aug 4 closing price
Capitalization
3.06B
6 days until earnings call
Interact to see
Advertisement

AVBP vs KYMR

Header iconAVBP vs KYMR Comparison
Open Charts AVBP vs KYMRBanner chart's image
ArriVent BioPharma
Price$18.78
Change+$0.12 (+0.64%)
Volume$229.87K
Capitalization689.14M
Kymera Therapeutics
Price$43.66
Change+$0.70 (+1.63%)
Volume$379.79K
Capitalization3.06B
AVBP vs KYMR Comparison Chart in %
Loading...
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVBP vs. KYMR commentary
Aug 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 05, 2025
Stock price -- (AVBP: $18.78 vs. KYMR: $43.66)
Brand notoriety: AVBP and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 60% vs. KYMR: 41%
Market capitalization -- AVBP: $689.14M vs. KYMR: $3.06B
AVBP [@Biotechnology] is valued at $689.14M. KYMR’s [@Biotechnology] market capitalization is $3.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $213.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • AVBP’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than AVBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • AVBP’s TA Score: 4 bullish, 5 bearish.
  • KYMR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than AVBP.

Price Growth

AVBP (@Biotechnology) experienced а -10.27% price change this week, while KYMR (@Biotechnology) price change was -1.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.94%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +10.52%.

Reported Earning Dates

AVBP is expected to report earnings on Aug 13, 2025.

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.06B) has a higher market cap than AVBP($689M). KYMR YTD gains are higher at: 8.526 vs. AVBP (-29.505). AVBP has higher annual earnings (EBITDA): -140.41M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. AVBP (176M). AVBP has less debt than KYMR: AVBP (138K) vs KYMR (86.3M). KYMR has higher revenues than AVBP: KYMR (58.9M) vs AVBP (0).
AVBPKYMRAVBP / KYMR
Capitalization689M3.06B22%
EBITDA-140.41M-232.67M60%
Gain YTD-29.5058.526-346%
P/E RatioN/AN/A-
Revenue058.9M-
Total Cash176M463M38%
Total Debt138K86.3M0%
TECHNICAL ANALYSIS
Technical Analysis
AVBPKYMR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KMKYX79.36N/A
N/A
Kinetics Market Opportunities Inst
REIZX14.18N/A
N/A
Third Avenue International RE Val Z
HDGRX34.86N/A
N/A
Hartford Dividend and Growth R3
FTFGX8.69N/A
N/A
Templeton Foreign R6
AWMIX20.47N/A
N/A
CIBC Atlas Mid Cap Equity Institutional

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with SYRE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
+0.64%
SYRE - AVBP
48%
Loosely correlated
-0.62%
CRNX - AVBP
44%
Loosely correlated
+1.36%
KYMR - AVBP
43%
Loosely correlated
+1.63%
IPSC - AVBP
43%
Loosely correlated
+6.20%
LGND - AVBP
42%
Loosely correlated
+2.01%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+1.63%
NRIX - KYMR
67%
Closely correlated
+2.17%
VERA - KYMR
59%
Loosely correlated
-2.39%
CGON - KYMR
56%
Loosely correlated
-0.84%
LYRA - KYMR
54%
Loosely correlated
+3.80%
IDYA - KYMR
53%
Loosely correlated
+3.09%
More